Terms: = Prostate cancer AND CASP8, ALPS2B, 841, ENSG00000064012, MGC78473, CAP4, MACH, MCH5, FLICE AND Diagnosis
31 results:
1. Safety assessment, radioiodination and preclinical evaluation of antinuclear antibody as novel medication for prostate cancer in mouse xenograft model.
Nguyen TMC; Hoang LDC; Nguyen TKG; Nguyen TN; Nguyen QC; Nguyen TB; Dang HHQ; Bui VC; Pham TM; Nguyen TT
Sci Rep; 2023 Oct; 13(1):18753. PubMed ID: 37907691
[TBL] [Abstract] [Full Text] [Related]
2. Disparities in time to prostate cancer treatment initiation before and after the Affordable Care Act.
Janopaul-Naylor JR; Corriher TJ; Switchenko J; Hanasoge S; Esdaille A; Mahal BA; Filson CP; Patel SA
Cancer Med; 2023 Sep; 12(17):18258-18268. PubMed ID: 37537835
[TBL] [Abstract] [Full Text] [Related]
3. Development and validation of a clinic machine-learning nomogram for the prediction of risk stratifications of prostate cancer based on functional subsets of peripheral lymphocyte.
Yang C; Liu Z; Fang Y; Cao X; Xu G; Wang Z; Hu Z; Wang S; Wu X
J Transl Med; 2023 Jul; 21(1):465. PubMed ID: 37438820
[TBL] [Abstract] [Full Text] [Related]
4. [The value of machine learning models based on biparametric MRI for diagnosis of prostate cancer and clinically significant prostate cancer].
Qiao XM; Hu CH; Hu S; Hu CH; Wang XM; Shen JK; Ji LB; Song Y; Bao J
Zhonghua Yi Xue Za Zhi; 2023 May; 103(19):1446-1454. PubMed ID: 37198106
[No Abstract] [Full Text] [Related]
5. Long-term Risks of Depression and Suicide Among Men with prostate cancer: A National Cohort Study.
Crump C; Stattin P; Brooks JD; Sundquist J; Bill-Axelson A; Edwards AC; Sundquist K; Sieh W
Eur Urol; 2023 Sep; 84(3):263-272. PubMed ID: 37169640
[TBL] [Abstract] [Full Text] [Related]
6.
Moradi F; Duan H; Song H; Davidzon GA; Chung BI; Thong AEC; Loening AM; Ghanouni P; Sonn G; Iagaru A
J Nucl Med; 2022 Dec; 63(12):1822-1828. PubMed ID: 35512996
[TBL] [Abstract] [Full Text] [Related]
7. Differences in prostate cancer Genomes by Self-reported Race: Contributions of Genetic Ancestry, Modifiable cancer Risk Factors, and Clinical Factors.
Stopsack KH; Nandakumar S; Arora K; Nguyen B; Vasselman SE; Nweji B; McBride SM; Morris MJ; Rathkopf DE; Slovin SF; Danila DC; Autio KA; Scher HI; Mucci LA; Solit DB; Gönen M; Chen Y; Berger MF; Schultz N; Abida W; Kantoff PW
Clin Cancer Res; 2022 Jan; 28(2):318-326. PubMed ID: 34667026
[TBL] [Abstract] [Full Text] [Related]
8. cancer incidence in World Trade Center-exposed and non-exposed male firefighters, as compared with the US adult male population: 2001-2016.
Webber MP; Singh A; Zeig-Owens R; Salako J; Skerker M; Hall CB; Goldfarb DG; Jaber N; Daniels RD; Prezant DJ
Occup Environ Med; 2021 Oct; 78(10):707-714. PubMed ID: 34507965
[TBL] [Abstract] [Full Text] [Related]
9. prostate cancer outcomes disparities: Population survival analysis in an ethnically diverse nation.
Matti B; Zargar-Shoshtari K
Urol Oncol; 2021 Jun; 39(6):367.e19-367.e26. PubMed ID: 33858746
[TBL] [Abstract] [Full Text] [Related]
10. Patterns of primary staging for newly diagnosed prostate cancer in the era of prostate specific membrane antigen positron emission tomography: A population-based analysis.
Papa N; Perera M; Murphy DG; Lawrentschuk N; Evans M; Millar JL; Bolton D
J Med Imaging Radiat Oncol; 2021 Oct; 65(6):649-654. PubMed ID: 33666330
[TBL] [Abstract] [Full Text] [Related]
11. prostate cancer with low burden skeletal disease at diagnosis: outcome of concomitant radiotherapy on primary tumor and metastases.
Deantoni CL; Fodor A; Cozzarini C; Fiorino C; Brombin C; Di Serio C; Calandrino R; Di Muzio N
Br J Radiol; 2020 Apr; 93(1108):20190353. PubMed ID: 31971828
[TBL] [Abstract] [Full Text] [Related]
12. Comparison of biparametric and multiparametric MRI in the diagnosis of prostate cancer.
Xu L; Zhang G; Shi B; Liu Y; Zou T; Yan W; Xiao Y; Xue H; Feng F; Lei J; Jin Z; Sun H
Cancer Imaging; 2019 Dec; 19(1):90. PubMed ID: 31864408
[TBL] [Abstract] [Full Text] [Related]
13. High levels of serum glypican-1 indicate poor prognosis in pancreatic ductal adenocarcinoma.
Zhou CY; Dong YP; Sun X; Sui X; Zhu H; Zhao YQ; Zhang YY; Mason C; Zhu Q; Han SX
Cancer Med; 2018 Nov; 7(11):5525-5533. PubMed ID: 30358133
[TBL] [Abstract] [Full Text] [Related]
14. ADC Metrics From Multiparametric MRI: Histologic Downgrading of Gleason Score 9 or 10 prostate cancers Diagnosed at Nontargeted Transrectal Ultrasound-Guided Biopsy.
Sadoughi N; Krishna S; McInnes MDF; Flood TA; Breau RH; Morash C; Schieda N
AJR Am J Roentgenol; 2018 Sep; 211(3):W158-W165. PubMed ID: 29995495
[TBL] [Abstract] [Full Text] [Related]
15. Characteristics of people living in Italy after a cancer diagnosis in 2010 and projections to 2020.
Guzzinati S; Virdone S; De Angelis R; Panato C; Buzzoni C; Capocaccia R; Francisci S; Gigli A; Zorzi M; Tagliabue G; Serraino D; Falcini F; Casella C; Russo AG; Stracci F; Caruso B; Michiara M; Caiazzo AL; Castaing M; Ferretti S; Mangone L; Rudisi G; Sensi F; Mazzoleni G; Pannozzo F; Tumino R; Fusco M; Ricci P; Gola G; Giacomin A; Tisano F; Candela G; Fanetti AC; Pala F; Sardo AS; Rugge M; Botta L; Dal Maso L
BMC Cancer; 2018 Feb; 18(1):169. PubMed ID: 29426306
[TBL] [Abstract] [Full Text] [Related]
16. Immortal time bias in pharmacoepidemiological studies on cancer patient survival: empirical illustration for beta-blocker use in four cancers with different prognosis.
Weberpals J; Jansen L; van Herk-Sukel MPP; Kuiper JG; Aarts MJ; Vissers PAJ; Brenner H
Eur J Epidemiol; 2017 Nov; 32(11):1019-1031. PubMed ID: 28864947
[TBL] [Abstract] [Full Text] [Related]
17. prostate cancer outcomes for men who present with symptoms at diagnosis.
Beckmann KR; O'Callaghan ME; Ruseckaite R; Kinnear N; Miller C; Evans S; Roder DM; Moretti K;
BJU Int; 2017 Jun; 119(6):862-871. PubMed ID: 27489140
[TBL] [Abstract] [Full Text] [Related]
18. Financial Insolvency as a Risk Factor for Early Mortality Among Patients With cancer.
Ramsey SD; Bansal A; Fedorenko CR; Blough DK; Overstreet KA; Shankaran V; Newcomb P
J Clin Oncol; 2016 Mar; 34(9):980-6. PubMed ID: 26811521
[TBL] [Abstract] [Full Text] [Related]
19. A population-based study on the association between educational length, prostate-specific antigen testing and use of prostate biopsies.
Nordström T; Bratt O; Örtegren J; Aly M; Adolfsson J; Grönberg H
Scand J Urol; 2016; 50(2):104-9. PubMed ID: 26625178
[TBL] [Abstract] [Full Text] [Related]
20. Prostatitis, other genitourinary infections and prostate cancer: results from a population-based case-control study.
Boehm K; Valdivieso R; Meskawi M; Larcher A; Schiffmann J; Sun M; Graefen M; Saad F; Parent MÉ; Karakiewicz PI
World J Urol; 2016 Mar; 34(3):425-30. PubMed ID: 26108732
[TBL] [Abstract] [Full Text] [Related]
[Next]
